RXI Pharma (RXII) Reports In-Line Q3 EPS

November 10, 2016 7:24 AM EST
Get Alerts RXII Hot Sheet
Trade RXII Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

RXI Pharma (NASDAQ: RXII) reported Q3 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on RXI Pharma (RXII) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment